Table 4.

Prevalence of glucose-lowering, blood pressure-lowering, lipid-lowering medications used among adult NHANES participants with diagnosed diabetes, 1992-2002 to 2015-2020

	1999-2002	2003-2006	2007-2010	2011-2014	2015-2020	P for differences
Glucose-lowering medications
Total participants	84.7	85.4	88.2	84.2	82.7	<0.001
Body mass index category
Normal weight	75.8	80.3	85.5	78.5	80.2	0.266
Overweight	85.8	82.6	85.2	84.6	83.8	0.823
Obese class I	83.9	89.4	89.3	85.1	81.5	0.004
Obese class II	91.2	88.1	88.2	84.9	85.2	0.390
Obese class III	93.2	90.8	94.0	85.8	80.1	<0.001
P for differences	<0.001	0.004	<0.001	0.072	0.226
Blood pressure-lowering medications
Total participants	51.8	60.2	66.1	61.9	62.5	<0.001
Body mass index category
Normal weight	35.3	46.6	54.6	48.1	48.0	0.011
Overweight	51.0	55.3	60.3	56.5	58.1	0.121
Obese class I	55.4	61.7	69.3	66.4	62.5	0.007
Obese class II	63.6	70.0	71.3	70.2	69.5	0.633
Obese class III	66.4	77.1	72.7	73.5	72.1	0.540
P for differences	<0.001	<0.001	<0.001	<0.001	<0.001
Lipid-lowering medications
Total participants	27.8	40.1	49.0	55.3	53.9	<0.001
Body mass index category
Normal weight	21.4	37.3	44.6	50.7	49.4	<0.001
Overweight	31.5	35.5	47.6	54.3	55.8	<0.001
Obese class I	29.4	40.8	52.3	55.9	54.9	<0.001
Obese class II	25.2	50.7	50.6	58.4	54.8	<0.001
Obese class III	31.3	46.3	46.6	57.1	49.2	0.001
P for differences	0.136	0.024	0.132	0.049	0.176

^aAdjusted for age, sex and race.

^bThe participants were classified in five body mass index categories: <25.0 (normal weight), 25.0-29.9 (overweight), 30-34.9 (obese class I), 35-39.9 (obese class II), and ≥40 (obese class III).